MiMedx (NSDQ:MDXG) said this week that it completed the divestiture of its subsidiary, Stability Biologics, back to the former stockholders of Stability, Inc.
The deal, which closed on Sept. 30, included a promissory note issued by Stability Biologics for $3.5 million in favor of MiMedx.
Get the full story at our sister site, Drug Delivery Business News.
The post MiMedx closes Stability Biologics sale appeared first on MassDevice.
from MassDevice http://ift.tt/2hUsONf
Cap comentari:
Publica un comentari a l'entrada